Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances β-Amyloid Production In Vivo
暂无分享,去创建一个
M. Mercken | Y. Matsuoka | P. Mathews | W. Noble | Vicki Olm | Kate Gaynor | J. Lafrancois | Lili Wang | K. Duff | Mark P. Burns
[1] T. Bird,et al. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. , 2004, The American journal of pathology.
[2] Raphael Kopan. Faculty Opinions recommendation of Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. , 2003 .
[3] R. Pepperkok,et al. Inhibition of Intracellular Cholesterol Transport Alters Presenilin Localization and Amyloid Precursor Protein Processing in Neuronal Cells , 2002, The Journal of Neuroscience.
[4] S. Younkin,et al. Cholesterol-Dependent γ-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains , 2002, Neurobiology of Disease.
[5] B. Hyman,et al. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide , 2001, Nature Cell Biology.
[6] M. Mercken,et al. A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease , 2001, Neurobiology of Disease.
[7] R. Vassar. The beta-secretase, BACE: a prime drug target for Alzheimer's disease. , 2001, Journal of molecular neuroscience : MN.
[8] C. Schweiger. [Statins and the risk of dementia]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[9] Y. Ihara,et al. Accumulation and Aggregation of Amyloid β-Protein in Late Endosomes of Niemann-Pick Type C Cells* , 2001, The Journal of Biological Chemistry.
[10] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[11] Mikio Shoji,et al. Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease , 2001, The Journal of Neuroscience.
[12] D. Burns,et al. Cholesterol Is Sequestered in the Brains of Mice with Niemann‐Pick Type C Disease but Turnover Is Increased , 2000, Journal of neuropathology and experimental neurology.
[13] G. Celesia,et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.
[14] Rong Wang,et al. Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.
[15] B. Strooper. Alzheimer's disease: Closing in on γ-secretase , 2000, Nature.
[16] J. Dietschy,et al. Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Dietschy,et al. Cholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein. , 1999, The American journal of physiology.
[18] P. Lansbury,et al. A detergent-insoluble membrance compartment contains Aβ in vivo , 1998, Nature Medicine.
[19] B. Strooper,et al. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] B. Greenberg,et al. Turnover of Amyloid β-Protein in Mouse Brain and Acute Reduction of Its Level by Phorbol Ester , 1998, The Journal of Neuroscience.
[21] W. Pavan,et al. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. , 1997, Science.
[22] K. G. Coleman,et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.
[23] J. Pitha,et al. Intracellular Trafficking of Cholesterol Monitored with a Cyclodextrin* , 1996, The Journal of Biological Chemistry.
[24] W. Klein,et al. Cholesterol Modulates -Secretase Cleavage of Amyloid Precursor Protein (*) , 1996, The Journal of Biological Chemistry.
[25] E. Krul,et al. Secretion of apolipoprotein E by an astrocytoma cell line , 1992, Journal of neuroscience research.
[26] C. Finch,et al. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. , 1991, Brain research. Molecular brain research.
[27] J. Taylor,et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.
[28] L. Marlow,et al. Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. , 2002, Journal of molecular neuroscience : MN.
[29] Vicki Olm,et al. Statin therapy for Alzheimer's disease: will it work? , 2002, Journal of molecular neuroscience : MN.
[30] L. Marlow,et al. Lipid rafts play an important role in Aβ biogenesis by regulating the β-secretase pathway , 2002, Journal of Molecular Neuroscience.
[31] F. Goot,et al. Separation of early steps in endocytic membrane transport , 1997, Electrophoresis.
[32] B. Trapp,et al. Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve , 1989, Glia.